What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

PARTIALLY ADDRESSED

While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and how much ketosis provides benefit vs harm. The 'metabolic steal syndrome' hypothesis suggests timing could be critical but remains untested. Source: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)

Priority: 0.85 Domain: metabolic-neuroscience Hypotheses: 1
📊 Landscape Analysis

Landscape Summary: What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? is a 0.85 priority gap in metabolic-neuroscience. It has 1 linked hypotheses with average composite score 0.608. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? — INVOKE-2 (completed)

📈 Living Dashboards
1
Hypotheses
0.608
Top Score
0.608
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
The Glial Ketone Metabolic Shunt Hypothesis
Target: HMGCS2 Pathway: Astrocyte ketogenesis (HMGCS2)
0.608
score
🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed
📈 The Glial Ketone Metabolic Shunt Hypothesis score=0.608 2026-04-02T20:53
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps